Duchenne's Muscular Dystrophy (DMD) Completed Phase 3 Trials for Ataluren (DB05016)

Also known as: Duchenne's Muscular Dystrophy / Duchenne Muscular Dystrophy (DMD) / Duchenne Muscular Dystrophy / Muscular Dystrophy, Duchenne / Muscular dystrophy

IndicationStatusPhase
DBCOND0066749 (Duchenne's Muscular Dystrophy (DMD))Completed3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01557400Study of Ataluren for Previously Treated Patients With nmDBMD in Europe, Israel, Australia, and CanadaTreatment